Advanced search
Publication Cover
Current Medical Research and Opinion Volume 31, 2015 - Issue 3
Submit an article Journal homepage
349
Views
19
CrossRef citations to date
0
Altmetric
Original article

Intranasal budesonide in children affected by persistent allergic rhinitis and its effect on nasal patency and Nasal Obstruction Symptom Evaluation (NOSE) score

Anna Maria Zicari‘Sapienza’ University of Rome, Department of Pediatrics, Rome, Italy
,
Francesca Occasi‘Sapienza’ University of Rome, Department of Pediatrics, Rome, ItalyCorrespondence[email protected]
,
Montanari Giulia‘Sapienza’ University of Rome, Department of Pediatrics, Rome, Italy
,
Luciana Indinnimeo‘Sapienza’ University of Rome, Department of Pediatrics, Rome, Italy
,
Giovanna De Castro‘Sapienza’ University of Rome, Department of Pediatrics, Rome, Italy
,
Giancarlo Tancredi‘Sapienza’ University of Rome, Department of Pediatrics, Rome, Italy
&
Marzia Duse‘Sapienza’ University of Rome, Department of Pediatrics, Rome, Italy
 show all
Pages 391-396 | Accepted 14 Jan 2015, Published online: 09 Feb 2015

References

  • Bjorksten B, Clayton T, Ellwood P, et al. Worldwide time trends for symptoms of rhinitis and conjunctivitis: phase III of the International Study of Asthma and Allergies in Childhood. Pediatr Allergy Immunol 2008;19:110-24
  • Zicari AM, Occasi F, Cesoni Marcelli C, et al. Assessing the relationship between serum resistin and nasal obstruction in children with allergic rhinitis. Am J Rhinol Allergy 2013;27:127-30
  • Bousquet J, Schünemann HJ, Samolinski B, et al. World Health Organization Collaborating Center for Asthma and Rhinitis. Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol 2012;130:1049-62
  • Stanaland BE. Once-daily budesonide aqueous nasal spray for allergic rhinitis: a review. Clin Ther 2004;26:473-92
  • Ciprandi G, Cirillo I, Klersy C, et al. Nasal obstruction is the key symptom in hay fever patients. Otolaryngol Head Neck Surg 2005;133:429-35
  • Stewart MG, Witsell DL, Smith TL, et al. Development and validation of the Nasal Obstruction Symptom Evaluation (NOSE) scale. Otolaryngol Head Neck Surg 2004;130:157-63
  • Mozzanica F, Urbani E, Atac M, et al. Reliability and validity of the Italian nose obstruction symptom evaluation (I-NOSE) scale. Eur Arch Otorhinolaryngol 2013;270:3087-94
  • André RF, Vuyk HD, Ahmed A, et al. Correlation between subjective and objective evaluation of the nasal airway. A systematic review of the highest level of evidence. Clin Otolaryngol 2009;34:518-25
  • Priftis KN, Drigopoulos K, Sakalidou A, et al. Subjective and objective nasal obstruction assessment in children with chronic rhinitis. Int J Pediatr Otorhinolaryngol 2006;70:501-5
  • Nathan RA, Eccles R, Howarth PH, et al. Objective monitoring of nasal patency and nasal physiology in rhinitis. J Allergy Clin Immunol 2005;115:S442-59
  • Gold MS, Kemp AS. Atopic disease in childhood. Med J Aust 2005;182:298-304
  • Van Asperen PP, Kemp AS, Mellis CM. Skin test reactivity and clinical allergen sensitivity in infancy. J Allergy Clin Immunol 1984;73:381-6
  • Clement PA. Committee report on standardization of rhinomanometry. Rhinology 1984;22:151-5
  • Zapletal A, Chalupovà J. Nasal airflow and resistance measured by active anterior rhinomanometry in healthy children and adolescents. Pediatr Pulmonol 2002;33:174-80
  • Scadding GK. Corticosteroids in the treatment of pediatric allergic rhinitis. J Allergy Clin Immunol 2001;108:S59-64
  • Stanaland BE. Once-daily budesonide aqueous nasal spray for allergic rhinitis: a review. Clin Ther 2004;26:473-92
  • Henriksen JM, Wenzel A. Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing, and asthma. Am Rev Respir Dis 1984;130:1014-18
  • Day JH, Andersson CB, Briscoe MP. Efficacy and safety of intranasal budesonide in the treatment of perennial rhinitis in adults and children. Ann Allergy 1990;64:445-50
  • Fokkens WJ, Cserháti E, dos Santos JM, et al. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours. Ann Allergy Asthma Immunol 2002;89:279-84

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.